Raymond James Financial Services Advisors’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-6,642
| Closed | -$205K | – | 3286 |
|
|
2021
Q3 | $205K | Sell |
6,642
-30
| -0.4% | -$926 | ﹤0.01% | 2961 |
|
|
2021
Q2 | $217K | Sell |
6,672
-6,866
| -51% | -$223K | ﹤0.01% | 2950 |
|
|
2021
Q1 | $512K | Buy |
13,538
+2,906
| +27% | +$110K | ﹤0.01% | 2268 |
|
|
2020
Q4 | $503K | Buy |
10,632
+5,306
| +100% | +$251K | ﹤0.01% | 2139 |
|
|
2020
Q3 | $172K | Sell |
5,326
-233
| -4% | -$7.53K | ﹤0.01% | 2572 |
|
|
2020
Q2 | $245K | Buy |
+5,559
| New | +$245K | ﹤0.01% | 2358 |
|